Acyclovir Dosing for Chickenpox Prophylaxis

Prophylaxis Indications and Timing

• The Centers for Disease Control and Prevention recommends acyclovir prophylaxis when varicella-zoster immune globulin (VZIG) is not available or more than 96 hours have passed since exposure to varicella-zoster virus 1, 3
• Prophylactic treatment with oral acyclovir should be initiated within 7-10 days of exposure to chickenpox 4, 1
• The prophylactic course should continue for 5-7 days 1, 3

Dosing by Population

• For children, the American Academy of Pediatrics recommends 20 mg/kg body weight (maximum 800 mg per dose) orally 4 times daily for 5-7 days 1
• For adults and adolescents, the recommended dose is 800 mg orally 4-5 times daily for 7 days, as suggested by the Infectious Diseases Society of America 4

Special Populations

• For immunocompromised patients with hypogammaglobulinemia who are susceptible to VZV, prophylaxis with acyclovir is recommended if VZIG is not available, according to the National Institute of Allergy and Infectious Diseases 4, 5
• Immunocompromised patients may require more aggressive prophylaxis and should be monitored closely, as recommended by the Centers for Disease Control and Prevention 1, 6

Clinical Considerations

• The first-line option for post-exposure prophylaxis in high-risk individuals is varicella-zoster immune globulin (VZIG) administered within 96 hours of exposure, as recommended by the Centers for Disease Control and Prevention 1, 3
• Acyclovir prophylaxis should be considered as an alternative when VZIG is not available or when more than 96 hours have passed since exposure, according to the American College of Obstetricians and Gynecologists 1, 3

Efficacy and Limitations

• Acyclovir does not eradicate latent virus or affect subsequent risk, frequency, or severity of recurrences, as stated by the Infectious Diseases Society of America 2